Effects of Treatment with Temsirolimus versus Interferon Alpha on Survival of Patients with Metastatic Renal Cell Carcinoma – Single-Center Real-World Experience

Effects of Treatment with Temsirolimus versus Interferon Alpha on Survival of Patients with Metastatic Renal Cell Carcinoma – Single-Center Real-World Experience

Vascular endothelial growth factor (VEGF) and mammalian target of rapamycin (mTOR) inhibitors are two main groups of drugs for targeted treatment of metastatic renal cell carcinoma (mRCC). Inhibition of angiogenesis and other growth pathways that are pivotal for tumor progression lead to signific...

Full description

Saved in:
Bibliographic Details
Main Authors: Ivan Levakov, Saša Vojinov, Miloš Maletin, Dimitrije Jeremić, Mladen Popov, Olivera Levakov, Dragan Grbić
Format: Article
Language:English
Published: Sestre Milosrdnice University hospital, Institute of Clinical Medical Research 2024-01-01
Series:Acta Clinica Croatica
Subjects:
Renal cell carcinoma
Temsirolimus
Interferon alpha
Survival
Online Access:https://hrcak.srce.hr/file/481989
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items